Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin DR in Type 2 Diabetes Mellitus
NCT01819272Phase 2Completed
- Sponsor
- Elcelyx Therapeutics
- Start
- Apr 2013
- Primary completion
- Sep 2013
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of metformin delayed release in type 2 diabetes mellitus (T2DM), sponsored by Elcelyx Therapeutics. Started Apr 2013; status: completed.
02
Drugs
metformin delayed release
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01819272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01819272.